US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Harvard Apparatus Regenerative Technology Inc.

1.69

-0.0320-1.86%

Volume:5.48K

Turnover:9.65K

Market Cap:29.68M

PE:-4.19

High:1.87

Open:1.84

Low:1.69

Close:1.72

52wk High:2.92

52wk Low:0.9359

Shares:17.58M

Float Shares:6.30M

Volume Ratio:2.18

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4028

EPS(LYR):-1.6870

ROE:-241.97%

ROA:-104.72%

PB:19.10

PE(LYR):-1.00

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Harvard Apparatus Regenerative Technology Raises $0.7 Million in Private Share Sale

CEO Junli He Acquires Common Shares of Harvard Apparatus Regenerative Technology Inc

Harvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin

Harvard Apparatus Regenerative Technology Inc. CEO Junli He Reports Acquisition of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HRGN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HRGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HRGN\",,,,,undefined,":{"symbol":"HRGN","market":"US","secType":"STK","nameCN":"Harvard Apparatus Regenerative Technology Inc.","latestPrice":1.688,"timestamp":1771621200000,"preClose":1.72,"halted":0,"volume":5475,"delay":15,"changeRate":-0.018604651162790715,"floatShares":6301954,"shares":17580744,"eps":-0.402774,"marketStatus":"Not Yet Opened","change":-0.032,"latestTime":"02-20 16:00:00 EST Delay","open":1.84,"high":1.87,"low":1.688,"amount":9652.9,"amplitude":0.105814,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.402774,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"exchange":"OTCQB","adjPreClose":1.72,"volumeRatio":2.179538095089437},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HRGN\",,,,,undefined,":{"symbol":"HRGN","floatShares":6301954,"roa":"-104.72%","roe":"-241.97%","lyrEps":-1.686981,"volumeRatio":2.179538095089437,"shares":17580744,"dividePrice":0,"high":1.87,"amplitude":0.105814,"preClose":1.72,"low":1.688,"week52Low":0.9359,"pbRate":"19.10","psRate":"39.94","week52High":2.92,"institutionHeld":0,"latestPrice":1.688,"eps":-0.402774,"divideRate":0,"volume":5475,"delay":15,"ttmEps":-0.402774,"open":1.84,"prevYearClose":1.84,"prevWeekClose":1.72,"prevMonthClose":1.68,"prevQuarterClose":1.84,"fiveDayClose":1.873,"twentyDayClose":1.7725,"sixtyDayClose":1.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HRGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-13","symbol":"HRGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"HRGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-13","symbol":"HRGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-02","symbol":"HRGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1712030400000,"reportTimeType":"post","actualEps":null},{"date":"2023-11-13","symbol":"HRGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1699866000000,"name":null,"time":"Pre-Market","dateTimestamp":1699851600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HRGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HRGN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HRGN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601816858","title":"Harvard Apparatus Regenerative Technology Raises $0.7 Million in Private Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2601816858","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601816858?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:06","pubTimestamp":1767712014,"startTime":"0","endTime":"0","summary":"Harvard Apparatus Regenerative Technology Inc. has announced that it has entered into Securities Purchase Agreements with certain investors for a private placement of 411,765 shares of common stock, raising approximately $0.7 million at a purchase price of $1.70 per share. The shares were sold in an unregistered offering, relying on exemptions under Section 4 and Rule 506 of the Securities Act, as well as similar state law exemptions, limiting the sale to accredited investors. The agreements include customary representations, warranties, and covenants between the company and the investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL7dWCk5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRGN","BK4139"],"gpt_icon":0},{"id":"2588177211","title":"CEO Junli He Acquires Common Shares of Harvard Apparatus Regenerative Technology Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2588177211","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588177211?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:54","pubTimestamp":1764611677,"startTime":"0","endTime":"0","summary":"Junli He, CEO and Director of Harvard Apparatus Regenerative Technology Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL6yQmFg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CEO Junli He Acquires Common Shares of Harvard Apparatus Regenerative Technology Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRGN","BK4139"],"gpt_icon":0},{"id":"2581067273","title":"Harvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581067273?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:23","pubTimestamp":1762431789,"startTime":"0","endTime":"0","summary":"Harvard Apparatus Regenerative Technology Inc. reported third quarter 2025 revenue of $20.6 million, compared to $22.0 million in the same period last year. Gross margin was $12.0 million or 58.4% of revenue, up from 58.1% a year earlier. Adjusted EBITDA rose to $2.0 million from $1.3 million in the prior year quarter. The company recorded operating income of $0.2 million, compared to an operating loss of $1.9 million last year. Cash provided by operations reached $6.8 million, an increase from negative $0.3 million in the same period of 2024. The company cited strong demand, the highest backlog in nearly two years, and ongoing discussions regarding refinancing or repayment of its existing credit agreement. Fourth quarter 2025 guidance projects revenue between $22.5 million and $24.5 million, with gross margin expected between 58% and 60%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL5tzygS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRGN","BK4139"],"gpt_icon":0},{"id":"2572638675","title":"Harvard Apparatus Regenerative Technology Inc. CEO Junli He Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2572638675","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572638675?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:40","pubTimestamp":1759354800,"startTime":"0","endTime":"0","summary":"Junli He, CEO and Director of Harvard Apparatus Regenerative Technology Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL2Yd59k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Harvard Apparatus Regenerative Technology Inc. CEO Junli He Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HRGN"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HRGN\",params:#limit:6,delay:false,,,undefined,":[]}}